FRT vs SEPN · rev $1.28B vs rev $46.0M
FRT (FRT) versus Septerna, Inc. Common Stock (SEPN) — a side-by-side from cached financials, not a winner call.
FRT (FRT) common stock.
Septerna, Inc. Common Stock (SEPN) is a biotechnology company listed on NASDAQ.
Latest reported FRT revenue for 2025-12-31 was $1.28B. Net income was $411.1M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. FRT currently screens at market cap $0.
Latest reported SEPN revenue for 2025-12-31 was $46.0M. Net income was -$48.9M. Revenue was up 4174.5% from 2024-12-31 to 2025-12-31. SEPN currently screens at market cap $1.61B.
FRT currently screens at market cap $0. SEPN currently screens at market cap $1.61B.
Not investment advice. Open the FRT and SEPN stock pages for the full models.
Not investment advice.